[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"asxl3-gene-mutation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:asxl3-gene-mutation":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":20,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100309083","asxl-related-disorders-natural-history-study-100309083",false,"NCT03303716","ASXL-Related Disorders Natural History Study","Natural History Study for the ASXL-Related Disorders and Chromatinopathies","Inclusion Criteria:\n\n* Clinical or molecular diagnosis of an ASXL related disorder\n\nExclusion Criteria:\n\n* No clinical or molecular diagnosis of an ASXL related disorder","ALL",{"count":18,"type":19},200,"ESTIMATED","20 Years","OBSERVATIONAL","A registry focused on the natural history, management and treatment of patients with Bohring-Opitz Syndrome (ASXL1), Shashi-Pena Syndrome (ASXL2) and Bainbridge-Ropers Syndrome (ASXL3).",[24,25,26,27,28,29],"Bohring-Opitz Syndrome","ASXL1 Gene Mutation","Shashi-Pena Syndrome","ASXL2 Gene Mutation","Bainbridge-Ropers Syndrome","ASXL3 Gene Mutation","RECRUITING","2025-12-18",{"date":33,"type":34},"2025-12-26","ACTUAL",{"date":36,"type":34},"2017-09-20",{"date":38,"type":19},"2037-09",{"name":40,"class":41},"University of California, Los Angeles","OTHER"]